| Literature DB >> 29692000 |
Thi-Anh Pham1, Imran Shair Mohammad2, Van-Tuan Vu2, Xiao-Long Hu1, Chaurasiya Birendra2, Aftab Ulah2, Cui Guo1, Xian-Yu Lü1, Wen-Cai Ye3, Hao Wang1.
Abstract
A new phloroglucinol derivative, named eucalyptin B (1), along with five related known compounds (2 - 6), was isolated from the fruits of Eucalyptus globulus. Their structures were elucidated by means of 1D- and 2D-NMR spectroscopy, with the absolute configuration of 1 determined by electronic circular dichroism (ECD) calculations. All isolated compounds (1 - 6) were evaluated for their cytotoxic activities against lung (A549), breast (4T1), and skin (B16F10) cancer cell lines. On the basis of cell viability assay, the cytotoxic activity of eucalyptin B (1) was further confirmed by apoptosis assay. Additionally, after treatment with eucalyptin B (1), the apoptosis factor proteins (Bcl2 and Bax) and caspase-3 levels in A549 cells were also determined by Western-blot analysis. By cytotoxic assay, eucalyptin B (1) exhibited potent cytotoxicity against A549 cells with an IC50 value of 1.51 μm and induced concentration dependent apoptosis of up to 49%. Additionally, eucalyptin B (1) inhibited 5-fold and increased 10-folds in the level of Bcl2 and Bax, respectively. Furthermore, the 11-fold increase in the level of caspase-3 confirmed eucalyptin B (1) activated caspase dependent apoptosis pathway. In conclusion, the isolated compound eucalyptin B (1) has promising cytotoxic activity in tumor cells, especially in A549.Entities:
Keywords: zzm321990Eucalyptus globuluszzm321990; BCl2; Bax; apoptosis; caspase-3; cytotoxicity; eucalyptin B
Mesh:
Substances:
Year: 2018 PMID: 29692000 DOI: 10.1002/cbdv.201800052
Source DB: PubMed Journal: Chem Biodivers ISSN: 1612-1872 Impact factor: 2.408